BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Jun 29, 2009
 |  BC Extra  |  Top Story

FDA wants another alogliptin trial

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it received a complete response letter from FDA for an NDA for alogliptin ( SYR-322) as an adjunct to diet...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >